Koninklijke Philips N.v.

Philips shareholders approve all proposals at the AGM 2026

Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications